Mineralocorticoid receptor antagonism in AKI: A new hope?

Journal of the American Society of Nephrology

Volumn 27, Issue 2, 2016, Pages 335-337

  Juncos, Luis A ^a   Juncos, Luis I ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRASENTAN; BR 4628; CYSTEINE SULFINIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; EPLERENONE; MINERALOCORTICOID ANTAGONIST; OXOSTEROID; RENIN; SPIRONOLACTONE; UNCLASSIFIED DRUG; SULFENIC ACID DERIVATIVE;

ACUTE KIDNEY FAILURE; ADRENALECTOMY; BLOOD LEVEL; EDITORIAL; ENZYME INACTIVATION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; VASOCONSTRICTION; ANIMAL; DRUG EFFECTS; KIDNEY; MALE; VASCULARIZATION;

ANIMALS; KIDNEY; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RECEPTOR, ENDOTHELIN B; REPERFUSION INJURY; SULFENIC ACIDS;

EID: 84970928686     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015080866     Document Type: Editorial

References (18)

1. Susantitaphong P, Cruz DN, Cerdá J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL; Acute Kidney Injury Advisory Group of the American Society of Nephrology: World incidence of AKI: A metaanalysis. Clin J Am Soc Nephrol 8: 1482-1493, 2013
2. Cerdá J, Lameire N, Eggers P, Pannu N, Uchino S, Wang H, Bagga A, Levin A: Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 3: 881-886, 2008
3. Grams ME, Rabb H: The Distant organ effects of acute kidney injury. Kidney Int 81: 942-948, 2012
4. DrumlW: Systemic consequences of acute kidney injury. CurrOpin Crit Care 20: 613-619, 2014
5. Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58-66, 2014
6. Cerdá J, Liu KD, Cruz DN, Jaber BL, Koyner JL, Heung M, Okusa MD, Faubel S; AKI Advisory Group of the American Society of Nephrology: Promoting kidney function recovery in patients with AKI requiring RRT [published online ahead of print July 2, 2015]. Clin J Am Soc Nephrol doi:CJN. 01170215
7. Sharfuddin AA,Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189-200, 2011
8. Barrera-Chimal J, Prince S, Fadel F, El Moghrabi S, Warnock DG, Kolkhof P, Jaisser F: Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia. J Am Soc Nephrol 27: 398-404, 2016
9. Mejía-Vilet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA: Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293: F78-F86, 2007
10. Ramírez V, Trujillo J, Valdes R,UribeN,CruzC,Gamba G, BobadillaNA: Adrenalectomy prevents renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297: F932-F942, 2009
11. Tamargo J, Solini A, Ruilope LM: Comparison of agents that affect aldosterone action. Semin Nephrol 34: 285-306, 2014
12. Kolkhof P, Nowack C, Eitner F: Nonsteroidal antagonists of the mineralocorticoid receptor. Curr Opin Nephrol Hypertens 24: 417-424, 2015
13. Fagart J, Hillisch A, Huyet J, Bärfacker L, Fay M, Pleiss U, Pook E, Schäfer S, Rafestin-Oblin ME, Kolkhof P: A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J Biol Chem285: 29932-29940, 2010
14. Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F: Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: A randomized, double-blind trial. Eur Heart J 34: 2453-2463, 2013
15. Sánchez-Pozos K, Barrera-Chimal J, Garzón-Muvdi J, Pérez-Villalva R, Rodríguez-Romo R, Cruz C, Gamba G, Bobadilla NA: Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant 27: 3160-3169, 2012
16. Barrera-Chimal J, Pérez-Villalva R, Rodríguez-Romo R, Reyna J, Uribe N, Gamba G, Bobadilla NA: Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int 83: 93-103, 2013
17. Zager RA, Johnson AC, Andress D, Becker K: Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury. Kidney Int 84: 703-712, 2013
18. López-Farré A, Gómez-Garre D, Bernabeu F, López-Novoa JM: A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol 444: 513-522, 1991